Acta Med. 2022, 65: 37-40
https://doi.org/10.14712/18059694.2022.15
Rapidly Progressive Interstitial Lung Disease Associated with Melanoma Differentiation-Associated Gene 5 Antibody
Yosuke Maezawaa, Mami Naritaa, Riho Tanimuraa, Sou Hattoria, Hiroaki Satohb
aDivision of General Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
bDivision of Respiratory Medicine, University of Tsukuba, Mito Medical Center-Mito Kyodo General Hospital, Mito, Ibaraki, Japan
Received June 21, 2021
Accepted April 26, 2022
References
1. M, Economidou S, Liampas A, Zis P, Parperis K. Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review. Semin Arthritis Rheum 2022; 53: 151959.
<https://doi.org/10.1016/j.semarthrit.2022.151959>
2. M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005; 175: 2851-8.
<https://doi.org/10.4049/jimmunol.175.5.2851>
3. J, Xu H. COVID-19 Disease and Dermatomyositis: A Mini-Review. Front Immunol 2022; 12: 747116.
<https://doi.org/10.3389/fimmu.2021.747116>
<PubMed>
4. G, Wang Q, Wang Y, et al. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: A retrospective cohort study. Front Immunol 2021; 12: 791348.
<https://doi.org/10.3389/fimmu.2021.791348>
<PubMed>
5. Kitamura M, Sugimoto H. Clinically amyopathic dermatomyositis during the COVID-19 pandemic. Oxf Med Case Reports 2021 Aug; 2021(8): omab061.
6. M, Ohana M, Nespola B, Zanframundo G, Geny B, Meyer A. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Eur Respir J 2020; 56: 2001618.
<https://doi.org/10.1183/13993003.01618-2020>
<PubMed>
7. K, Honda T, Nakashima R, et al. HRCT features of ILD in dermatomyositis with anti-CADM-140 antibody. Respir Med 2011; 105: 1380-7.
<https://doi.org/10.1016/j.rmed.2011.05.006>
8. H, Sekine A, Baba T, et al. Radiological and pathological correlation in anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage. Intern Med 2016; 55: 2241-6.
<https://doi.org/10.2169/internalmedicine.55.5774>
9. F, Moezi P, Jahromi MG, Zeinali-Rafsanjani B. Comparison of chest CT findings in outpatient and hospitalized COVID-19 RT-PCR positive patients of Shiraz. J Med Imaging Radiat Sci 2022; 53: 107-12.
<https://doi.org/10.1016/j.jmir.2021.10.009>
<PubMed>
10. AH, Wani HA, Choh NA, Shah NN, Jehangir M. Spectrum of chest CT manifestations of coronavirus disease (COVID-19): A pictorial essay. Indian J Radiol Imaging 2021; 31(Suppl 1): S170-S7.
11. T, Takizawa N, Nagasaka T, et al. Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report. Medicine (Baltimore) 2020; 99: e18600.
<https://doi.org/10.1097/MD.0000000000018600>
<PubMed>
12. P, Navasakulpong A. Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease. Respirol Case Rep 2020; 9: e00701.
13. H, Tsujino K, Yamamoto Y, et al. Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease: A case report. Respir Med Case Rep 2020; 29: 101016.
14. J, Hayashi H, Yajima C, et al. Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations. Respir Med Case Rep 2019; 26: 193-6.
15. P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 2020; 395: 1033-4.
<https://doi.org/10.1016/S0140-6736(20)30628-0>
<PubMed>
16. AG, Sampaio NG, Rehwinkel J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Trends Microbiol 2019; 27: 75-85.
<https://doi.org/10.1016/j.tim.2018.08.007>
<PubMed>
17. H, Lan Y, Yao X, Lin S, Xie B. The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies. Virol J 2020; 17: 159.
<https://doi.org/10.1186/s12985-020-01432-9>
<PubMed>
